ZACHARY CAVINS: Open Payments
NPI 1386492882 · GRAYSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 18 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $349 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $269 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $138 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| ABBVIE INC. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $14 |
Products named: HETLIOZ, CAPLYTA, FANAPT, Auvelity, VRAYLAR, Qelbree, SLYND.
Industry payments across KY — which companies pay providers there.
